rs104886282
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The ENST00000328300.11(COL4A5):c.4475G>C(p.Gly1492Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1492V) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000328300.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A5 | NM_033380.3 | c.4475G>C | p.Gly1492Ala | missense_variant | 49/53 | ENST00000328300.11 | NP_203699.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A5 | ENST00000328300.11 | c.4475G>C | p.Gly1492Ala | missense_variant | 49/53 | 1 | NM_033380.3 | ENSP00000331902 | ||
COL4A5 | ENST00000361603.7 | c.4457G>C | p.Gly1486Ala | missense_variant | 47/51 | 2 | ENSP00000354505 | P1 | ||
COL4A5 | ENST00000515658.1 | c.272G>C | p.Gly91Ala | missense_variant | 3/4 | 5 | ENSP00000423520 | |||
COL4A5 | ENST00000510690.2 | n.969G>C | non_coding_transcript_exon_variant | 7/11 | 4 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 29, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 1486 of the COL4A5 protein (p.Gly1486Ala). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly1486 amino acid residue in COL4A5. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24304881). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects COL4A5 function (PMID: 18083113). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL4A5 protein function. ClinVar contains an entry for this variant (Variation ID: 24739). This missense change has been observed in individuals with Alport syndrome (PMID: 10094548; Invitae). This variant is not present in population databases (gnomAD no frequency). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at